Poorly Differentiated Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Poorly Differentiated Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating selpercatinib given before surgery for RET-altered thyroid cancers is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial update reports results from CaboNivoIpi (cabozantinib, nivolumab, ipilimumab) in advanced differentiated thyroid cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating PDR001 in combination therapy for radioiodine-refractory thyroid cancer is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]
A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating trametinib for increasing tumoral iodine incorporation in patients with recurrent or metastatic thyroid cancer; res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating whether adding selumetinib to radioactive iodine improves outcomes in patients with recurrent or metastatic thyroid…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer [Phase 2]
Phase 2 trial of cabozantinib-s-malate in patients with refractory thyroid cancer has been completed, with results posted in 2018. The study…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of pegylated liposomal doxorubicin (PLD) with cisplatin for advanced poorly differentiated thyroid …
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression [EARLY_Phase 1]
This early Phase 1 pilot trial in poorly differentiated thyroid cancer evaluated correlations with retinoid and PPAR gamma expression; resul…